In this LPS-induced thrombosis model, the direct FXa inhibitor edoxaban significantly inhibited hypercoagulability, fibrin deposition in the liver, and elevation of liver injury parameters in a dose-dependent manner. The gene discussed is F10; the disease is Venous thrombosis.